Pressmeddelanden2021-04-14T19:02:23+02:00

REGULATORISKA PRESSMEDDELANDEN


PRESSMEDDELANDEN

1802, 2020

Dr Kristian Sandberg suggested as new board member

Press release Februari 18, 2020 The board of directors of Lipum AB has suggested Dr Kristian Sandberg to be elected as new member of the board at an extraordinary general meeting held in Umeå on [...]

2911, 2019

Professor Anders Fasth joins the scientific advisory board

Press release November 29, 2019 Lipum has developed a biological drug candidate for treatment of chronic inflammatory diseases and aim for a better treatment of juvenile idiopathic arthritis (JIA), that affects children. Therefore, the scientific [...]

705, 2019

Pernilla Abrahamsson joins as Chief Operating Officer

Press release may 7, 2019 ”Lipum is a very interesting company in an exciting development. Soon in the clinical phase and I am looking forward to all challenges ahead of us”, says Pernilla Abrahamsson. [...]

1903, 2019

Lipum and Abzena sign integrated CMC agreement

Press release march 19 2019 Abzena, the global biologics gene to GMP partner research organization, announced it has signed an agreement to support an integrated CMC program with Lipum, a company developing treatments for chronic [...]

603, 2019

Umeåföretag tar nästa steg mot ett nytt läkemedel

Pressrelease 3 juni, 2019 Ladda ned pressrelase: Investerare satsar 25 MSEK på nytt läkemedel (pdf) » Umeåföretaget Lipum utvecklar ett biologiskt läkemedel för behandling av kroniska inflammationer. Tidigare pre-kliniska studier har visat mycket goda resultat [...]

2908, 2018

Lipum receives 2.2 M€ grant from Horizon 2020

Press release Aug 29, 2018 Lipum's unique approach for treatment of chronic inflammatory diseases receives 2.2 M€ support from EU Horizon 2020, the EU framework program for research and development, will grant 2.2 million euros [...]

INVESTOR RELATIONS

Till toppen